You are here:Home-Chemical Inhibitors & Agonists-Immunology/Inflammation-Toll-like Receptor (TLR)-SZU-106
SZU-106

Chemical Structure : SZU-106

CAS No.: 2064235-35-2

SZU-106 (SZU106)

Catalog No.: PC-49146Not For Human Use, Lab Use Only.

SZU-106 is a small molecule TLR7 agonist, selectively activates TLR7 and increases the expression of SEAP by activating the NF-κB pathway.

Packing Price Stock Quantity
25 mg Get quote
100 mg Get quote
200 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

SZU-106 is a small molecule TLR7 agonist, selectively activates TLR7 and increases the expression of SEAP by activating the NF-κB pathway.
SZU-106 (0.5-10 μM) increased the release of interferon (IFN)-γ and IL-6 in a dose-dependent manner after 24 h of treatment in mouse splenic lymphocytes.
SZU-106 with a pegylated linker could produce a novel whole-tumor-cell vaccine, which induced immune-activating responses in both in vitro and in vivo experiments.

Physicochemical Properties

M.Wt 603.633
Formula C27H37N7O9
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

1-(4-((6-amino-8-hydroxy-2-(2-methoxyethoxy)-9H-purin-9-yl)methyl)phenyl)-3,6-dioxo-10,13-dioxa-2,7-diazahexadecan-16-oic acid

References

1. Huju Chi, et al. Cells. 2022 Jun 21;11(13):1986.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: